• Pharma Regulatory Services in Singapore

    Overview

    With an advanced healthcare system, Singapore is regarded as a key drug market by renowned global pharmaceutical companies. Medicinal products in Singapore are regulated by the Health Science Authority (HSA) under Health Products Act 2007, and they must obtain necessary approvals to be distributed and marketed in the country. For innovator products, a New Drug Application (NDA) should be filed and for generic drugs, it should be a Generic Drug Application (GDA) application.

  • Regulatory Services in Singapore

    Overview

    Due to its central location in Asia, Singapore offers potential growth opportunities for Medical Devices, Pharmaceuticals, Cosmetics and Food Supplements manufacturers across the globe. The Health Sciences Authority (HSA) under the purview of Ministry of Health (MOH) regulates all the procedures. Though the Regulatory system in the region believed to be industry-friendly, it’s constantly evolving regulatory frameworks and registration & licensing procedures might pose a great challenge for manufacturers to keep pace with the standards.